Target Name: MRPS30-DT
NCBI ID: G100506674
Other Name(s): MRPS30 divergent transcript | BRCAT54 | MRPS30 divergent transcript, transcript variant 1

MRPS30-DT: A Drug Target / Disease Biomarker

MRPS30-DT is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the melanoma-associated protein (MAP) family, which is known for its role in the development and progression of melanoma. MRPS30-DT has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer.

The MAP family of proteins is characterized by the presence of a single transmembrane domain and a cytoplasmic tail. The MAP family has been implicated in various cellular processes, including cell signaling, adhesion, and migration. The melanoma-associated protein (MAP) family is a subgroup of the MAP family that is specifically associated with the development and progression of melanoma.

MRPS30-DT is a 19-kDa protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the MAP family and is highly conserved, with a similar amino acid sequence to other MAP proteins. MRPS30-DT has a characteristic tryptophan-rich region at its C-terminus and a hydrophobic region at its N-terminus.

MRPS30-DT has been shown to be involved in various cellular processes, including cell signaling, adhesion, and migration. For example, studies have shown that MRPS30-DT is involved in the regulation of cell adhesion and that it plays a role in the migration of cancer cells. Additionally, MRPS30-DT has been shown to be involved in the regulation of cell signaling, including the regulation of the PI3K/Akt signaling pathway.

As a potential drug target or biomarker, MRPS30-DT has been identified as a potential target for the treatment of various diseases, including cancer. For example, studies have shown that inhibiting the activity of MRPS30-DT has the potential to inhibit the growth and migration of cancer cells. Additionally, MRPS30-DT has been shown to be involved in the regulation of cell apoptosis, which is a process that is involved in cell death. Therefore, MRPS30-DT may be a useful biomarker for the diagnosis and prognosis of cancer.

In conclusion, MRPS30-DT is a protein that is expressed in various tissues of the body and is a member of the MAP family. It has been shown to be involved in various cellular processes, including cell signaling, adhesion, and migration, and has been identified as a potential drug target or biomarker for the treatment of cancer. Further research is needed to fully understand the role of MRPS30-DT in these processes and its potential as a drug target or biomarker.

Protein Name: MRPS30 Divergent Transcript

More Common Targets

MRPS31 | MRPS31P2 | MRPS31P4 | MRPS31P5 | MRPS33 | MRPS33P4 | MRPS34 | MRPS35 | MRPS35-DT | MRPS36 | MRPS36P4 | MRPS5 | MRPS6 | MRPS7 | MRPS9 | MRRF | MRS2 | MRS2P2 | MRTFA | MRTFB | MRTO4 | MS4A1 | MS4A10 | MS4A12 | MS4A13 | MS4A14 | MS4A15 | MS4A18 | MS4A2 | MS4A3 | MS4A4A | MS4A4E | MS4A5 | MS4A6A | MS4A6E | MS4A7 | MS4A8 | MSANTD1 | MSANTD2 | MSANTD3 | MSANTD4 | MSC | MSC-AS1 | MSGN1 | MSH2 | MSH3 | MSH4 | MSH5 | MSH5-SAPCD1 | MSH6 | MSI1 | MSI2 | MSL1 | MSL2 | MSL3 | MSL3P1 | MSLN | MSLNL | MSMB | MSMO1 | MSMP | MSN | MSNP1 | MSR1 | MSRA | MSRA-DT | MSRB1 | MSRB1P1 | MSRB2 | MSRB3 | MSRB3-AS1 | MSS51 | MST1 | MST1L | MST1P2 | MST1R | MSTN | MSTO1 | MSTO2P | MSX1 | MSX2 | MSX2P1 | MT1A | MT1B | MT1DP | MT1E | MT1F | MT1G | MT1H | MT1HL1 | MT1IP | MT1JP | MT1L | MT1M | MT1P1 | MT1P3 | MT1X | MT1XP1 | MT2A | MT3